Interferon (IFN)-α-2a is effective in patients with hepatitis D virus (HDV) infection, but adjunctive ribavirin does not provide additional benefit

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1518, 2005-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection

By  

Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Recurrent hepatitis C virus (HCV) infection after liver transplantation "can be safely treated" with PEG interferon (IFN)- -2b and ribavirin

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Interferon (IFN)- -2b is effective in patients with mild chronic hepatitis C

By  

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Modifications of the Immune Responsiveness in Patients with Hepatitis C Virus Infection following Treatment with IFN- / Ribavirin

By  

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 981-993

Bentham Science Publishers

Access to resources Recommend Favorite